Cargando…

Anti-Inflammatory Effects of Low-Dose Glucocorticoids Compensate for Their Detrimental Effects on Bone Mineral Density in Patients with Rheumatoid Arthritis

Objectives: This study aimed to provide reliable information on the impact of low-dose glucocorticoids (GCs) on the bone mineral density (BMD) of patients with rheumatoid arthritis (RA). Methods: This retrospective study enrolled 933 patients with RA who continued the consumption of GCs (GC group) a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Ji-Won, Jung, Ju-Yang, Kim, Hyoun-Ah, Suh, Chang-Hee
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8268831/ https://www.ncbi.nlm.nih.gov/pubmed/34209074 http://dx.doi.org/10.3390/jcm10132944

Ejemplares similares

Factors Determining Retreatment Time Interval of Rituximab in Korean Patients With Rheumatoid Arthritis
por: Kim, Ji-Won, et al.
Publicado: (2021)

The Assessment of Muscle Mass and Function in Patients with Long-Standing Rheumatoid Arthritis
por: Yun, Hye-Won, et al.
Publicado: (2021)

Biologic therapy for amyloid A amyloidosis secondary to rheumatoid arthritis treated with interleukin 6 therapy: Case report and review of literature
por: Jung, Ju-Yang, et al.
Publicado: (2021)

The impact of low-dose glucocorticoids on disease activity, bone mineral density, fragility fractures, and 10-year probability of fractures in patients with rheumatoid arthritis
por: Cheng, Tien-Tsai, et al.
Publicado: (2018)

Unveiling difficult-to-treat rheumatoid arthritis: long-term impact of biologic or targeted synthetic DMARDs from the KOBIO registry
por: Jung, Ju-Yang, et al.
Publicado: (2023)

Effect of Vitamin D Supplementation on Bone Mineral Density in Rheumatoid Arthritis Patients With Osteoporosis
por: Kwon, Oh Chan, et al.
Publicado: (2020)

Trabecular bone score as a supplementary tool for the discrimination of osteoporotic fractures in postmenopausal women with rheumatoid arthritis
por: Choi, Yong Jun, et al.
Publicado: (2017)

Bone mineral density in patients with Juvenile Rheumatoid Arthritis
por: Zhizho, Ye, et al.
Publicado: (2008)

Glucocorticoid management in rheumatoid arthritis: morning or night low dose?
por: Paolino, Sabrina, et al.
Publicado: (2017)

Glucocorticoids and chronotherapy in rheumatoid arthritis
por: Cutolo, Maurizio
Publicado: (2016)

Rheumatoid arthritis and risk factors for low bone mineral density
por: Arinoviche, R
Publicado: (2004)

Effect of long-term low dose prednisolone administration on bone mineral density: Relating to non-compliant women with rheumatoid arthritis
por: Heidari, Behzad, et al.
Publicado: (2018)

Benefits and risks of low-dose glucocorticoid treatment in the patient with rheumatoid arthritis
por: Kavanaugh, Arthur, et al.
Publicado: (2014)

The supplementary therapeutic DMARD role of low-dose glucocorticoids in rheumatoid arthritis
por: Cutolo, Maurizio, et al.
Publicado: (2014)

Sex and age do not modify the association between glucocorticoids and bone mineral density in patients with rheumatoid arthritis: a cross-sectional study
por: Palmowski, Andriko, et al.
Publicado: (2023)

The Effect of Discontinuing Denosumab in Patients With Rheumatoid Arthritis Treated With Glucocorticoids
por: Saag, Kenneth G., et al.
Publicado: (2022)

Roles of Interactions Between Toll-Like Receptors and Their Endogenous Ligands in the Pathogenesis of Systemic Juvenile Idiopathic Arthritis and Adult-Onset Still’s Disease
por: Jung, Ju-Yang, et al.
Publicado: (2020)

Effectiveness of bazedoxifene in preventing glucocorticoid-induced bone loss in rheumatoid arthritis patients
por: Cho, Soo-Kyung, et al.
Publicado: (2021)

Systemic Manifestations and Complications in Patients with Rheumatoid Arthritis
por: Kim, Ji-Won, et al.
Publicado: (2020)

Assessment of Distal Radius Bone Mineral Density in Osteoporosis Patients Receiving Denosumab, Including Those with Rheumatoid Arthritis and Those Receiving Oral Glucocorticoids
por: Matsuno, Hiroaki
Publicado: (2016)

Bone Mineral Density Changes in Patients with Recent-Onset Rheumatoid Arthritis
por: Hafez, Eman A., et al.
Publicado: (2011)

Association Between Bone Mineral Density and Autoantibodies in Patients With Rheumatoid Arthritis
por: Amkreutz, Josephine A. M. P., et al.
Publicado: (2021)

Bone mineral density status in patients with recent-onset rheumatoid arthritis
por: Ketabforoush, Arsh Haj Mohamad Ebrahim, et al.
Publicado: (2023)

Prevalence and Factors of Osteoporosis and High Risk of Osteoporotic Fracture in Patients with Ankylosing Spondylitis: A Multicenter Comparative Study of Bone Mineral Density and the Fracture Risk Assessment Tool
por: Kim, Ji-Won, et al.
Publicado: (2022)

Detrimental Effects of Endovascular Intervention in Active Rheumatoid Vasculitis
por: Park, Jong Kwon
Publicado: (2018)

Bodycomposition, bone mineral density and serum adipokines in juvenile idiopathic arthritis with previous glucocorticoid therapy
por: Markula-Patjas, Kati P, et al.
Publicado: (2014)

An Update on the Pathogenic Role of Neutrophils in Systemic Juvenile Idiopathic Arthritis and Adult-Onset Still’s Disease
por: Kim, Ji-Won, et al.
Publicado: (2021)

Prevalence and Fracture Risk of Osteoporosis in Patients with Rheumatoid Arthritis: A Multicenter Comparative Study of the FRAX and WHO Criteria
por: Choi, Sang Tae, et al.
Publicado: (2018)

Rheumatoid arthritis - a neuroendocrine immune disorder: glucocorticoid resistance, relative glucocorticoid deficiency, low-dose glucocorticoid therapy, and insulin resistance
por: Straub, Rainer H
Publicado: (2014)

Identification of a key gene module associated with glucocorticoid- induced derangement in bone mineral density in patients with asthma
por: Lee, Suh-Young, et al.
Publicado: (2019)

The comparable efficacy of denosumab on bone mineral density in rheumatoid arthritis patients with postmenopausal osteoporosis: A retrospective case-control study
por: Kim, Seong-Kyu, et al.
Publicado: (2023)

Risk of low bone mineral density in patients with rheumatoid arthritis treated with biologics
por: Takahashi, Kengo, et al.
Publicado: (2015)

Bone mineral density in children with systemic lupus erythematosus and juvenile rheumatoid arthritis
por: Kashef, Sara, et al.
Publicado: (2007)

Bone mineral density and fractures in patients with rheumatoid arthritis: the DXA-HIP project
por: Ebrahimiarjestan, Mina, et al.
Publicado: (2023)

Perspectives of Glucocorticoid Use in Patients with Rheumatoid Arthritis
por: Venter, Gabriella, et al.
Publicado: (2021)

Effects of denosumab on bone mineral density and bone turnover markers in rheumatoid arthritis patients switching from bisphosphonates
por: Kaneko, Tetsuya, et al.
Publicado: (2019)

ADAM17 Genetic Variants and the Response of TNF-α Inhibitor in Rheumatoid Arthritis Patients
por: Kim, Hyun Jeong, et al.
Publicado: (2020)

Ghrelin plasma levels, gastric ghrelin cell density and bone mineral density in women with rheumatoid arthritis
por: Maksud, F.A.N., et al.
Publicado: (2017)

Off-label use of tocilizumab to treat non-juvenile idiopathic arthritis in pediatric rheumatic patients: a literature review
por: Jung, Ju-Yang, et al.
Publicado: (2018)

Effects of Denosumab on Bone Metabolic Markers and Bone Mineral Density in Patients Treated with Glucocorticoids
por: Sawamura, Masato, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_rs03mqcjginntds9ru3r1m33t7